-+ 0.00%
-+ 0.00%
-+ 0.00%

Corcept Therapeutics holds annual shareholder meeting, backs amended 2024 incentive plan

PUBT·05/28/2026 20:15:23
Listen to the news
Corcept Therapeutics holds annual shareholder meeting, backs amended 2024 incentive plan
  • Corcept Therapeutics held its annual shareholder meeting on May 21, 2026.
  • Shareholders authorized an amendment to the 2024 Incentive Award Plan, expanding the share pool by 8 million shares; the amended plan took effect May 21.
  • Ernst & Young was ratified as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corcept Therapeutics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-038793), on May 28, 2026, and is solely responsible for the information contained therein.